Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381K Sell
6,066
-23,825
-80% -$1.66M 0.01% 996
2025
Q4
$1.98M Buy
29,891
+24,776
+484% +$1.6M 0.03% 714
2025
Q3
$344K Buy
+5,115
New +$405K 0.01% 975
2025
Q2
Sell
-5,860
Closed -$400K 1211
2025
Q1
$400K Buy
+5,860
New +$478K 0.01% 953
2024
Q4
Sell
-6,251
Closed -$419K 1215
2024
Q3
$419K Buy
+6,251
New +$513K 0.01% 936
2023
Q2
Sell
-10,041
Closed -$1.17M 1124
2023
Q1
$1.17M Sell
10,041
-500
-5% -$56K 0.06% 587
2022
Q4
$1.19M Buy
10,541
+1,269
+14% +$139K 0.07% 504
2022
Q3
$747K Buy
9,272
+551
+6% +$46.7K 0.05% 664
2022
Q2
$650K Sell
8,721
-3,415
-28% -$312K 0.05% 662
2022
Q1
$1.55M Buy
12,136
+2,252
+23% +$246K 0.1% 328
2021
Q4
$1.33M Buy
9,884
+6,924
+234% +$995K 0.17% 186
2021
Q3
$405K Buy
2,960
+476
+19% +$60K 0.05% 631
2021
Q2
$265K Sell
2,484
-10,436
-81% -$1M 0.09% 310
2021
Q1
$1.16M Buy
+12,920
New +$1.21M 0.37% 92
2016
Q1
Sell
-11,720
Closed -$240K 359
2015
Q4
$240K Buy
+11,720
New +$244K 0.11% 270
2015
Q2
Sell
-16,040
Closed -$250K 324
2015
Q1
$250K Buy
+16,040
New +$242K 0.14% 253
2014
Q2
Sell
-25,400
Closed -$263K 303
2014
Q1
$263K Hold
25,400
0.1% 248
2013
Q4
$225K Sell
25,400
-3,800
-13% -$30.1K 0.06% 315
2013
Q3
$206K Buy
+29,200
New +$185K 0.06% 309

Other funds holding DXCM

Algert Global's DXCM Position: Q1 2026 in Review

Algert Global reduced its DexCom (DXCM) stake by 80% in Q1 2026, selling an estimated $1.66M and leaving 6,066 shares worth $381K. The position accounts for 0.01% of the portfolio, ranked #996.

Algert Global first reported a position in DXCM in Q3 2013 and has held it in 19 quarters since. The position peaked at $1.98M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Algert Global held 6,066 shares of DexCom worth $381K as of Q1 2026.
  • Algert Global sold 23,825 DexCom shares in Q1 2026, an estimated $1.66M.
  • DexCom made up 0.01% of Algert Global's portfolio in Q1 2026, its #996 holding.
  • Algert Global first reported a position in DexCom in Q3 2013 and has held it in 19 quarters since.
  • Algert Global's DexCom position peaked at $1.98M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.